- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SIENTRA Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 228,55 | +0,04 % | UNITEDHEALTH GROUP INC im analytischen Fokus | ||
| THERMO FISHER | 419,35 | +0,08 % | THERMO FISHER SCIENTIFIC INC im strukturellen Gleichgewicht | ||
| TELADOC HEALTH | 4,463 | -0,61 % | Teladoc Health appoints Susan Salka to board of directors | ||
| ROKU | 76,02 | -1,26 % | Aurzen Official: Aurzen Announces Big Spring Sale for Aurzen Roku TV Smart Projectors | Designed to simplify both performance and usability, with a built-in Roku TV OS, Aurzen Roku TV Smart Projectors allow users to access thousands of streaming channels and apps instantly-without external... ► Artikel lesen | |
| RESMED | 191,95 | -0,05 % | ResMed Earnings Preview: What to Expect | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update | SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| HENRY SCHEIN | 63,38 | -0,09 % | Should You Retain Henry Schein Stock in Your Portfolio for Now? | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| ZIMMER BIOMET | 78,40 | +1,34 % | Argus reiterates Zimmer Biomet stock rating on restructuring plan | ||
| PETMED EXPRESS | 1,980 | +2,43 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart | BOULDER, CO / ACCESS Newswire / March 24, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the U.S. retail launch... ► Artikel lesen | |
| TANDEM DIABETES | 17,160 | +0,53 % | Truist upgrades Tandem Diabetes Care stock rating on Pay/Go model | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| QUIDELORTHO | 13,300 | +0,76 % | QuidelOrtho Corporation: Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer | SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appointment... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 171,70 | 0,00 % | Quest Diagnostics Earnings Preview: What to Expect |
Das Unternehmen SIENTRA INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIENTRA INC finden Sie auf Wallstreet Online.